Abstract
Background: Non-traditional risk factors including low levels of magnesium and high levels of uric acid have been associated with central obesity and cardiovascular disease.
Objective: To determine the association between waist circumference (WC) and non-traditional risk factors such as magnesium, phosphorus, and uric acid in indigenous children living at high altitudes. Methods: A total of 354 (166 M) indigenous school children, aged 9.6 + 2.3 years, were enrolled in a cross-sectional study in November 2011. Central obesity was defined as WC ≥ 90th percentile according to age and sex. Low magnesium and phosphorus levels were defined as serum magnesium <1.8 mg/dL and phosphorus <2.4 mg/dL. Hyperuricemia was defined as serum uric acid > 7 mg/dL. Results: The prevalence of central obesity was 6.8% (24/354). None of the children had hyperuricemia or low phosphorus levels. Hypoagnesemia was identified in 21.7% (57/263). There was a significant association between WC (z-score) and magnesium (r-015), uric acid (r0.28), phosphorus (r-0.30), HOMAIR (r0.49), triglycerides (r0.24), and HDL-C (r0.24). However, calcium, sodium, and potassium were not significantly associated with WC. As z-WC quartiles increased magnesium and phosphorus levels significantly decreased, whereas uric acid levels increased. Multiple linear regression analysis showed that z-WC was associated significantly and directly with uric acid (B0.31), triglycerides (B0.004), and HOMA-IR (B0.35); and inversely with magnesium (B-0.83) and phosphorus (B-0.25), adjusted for confounding variables (R2 0.34). Conclusion: Our results indicate that central obesity was associated significantly and inversely with magnesium and phosphorus and directly with uric acid in indigenous school children. Supplementation with magnesium and/or phosphorus could prevent future cardiovascular disease. Prospective and randomized studies should be performed to confirm these findings.Keywords: High altitude, indigenous children, magnesium, phosphorus, uric acid, waist circumference.
Graphical Abstract
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Association Between Waist Circumference and Magnesium and Uric Acid in Indigenous Argentinean Children Living at High Altitude
Volume: 14 Issue: 2
Author(s): Valeria Hirschler, M. Esteban, Claudio D. Gonzalez, Claudia Molinari and Luis Castano
Affiliation:
Keywords: High altitude, indigenous children, magnesium, phosphorus, uric acid, waist circumference.
Abstract: Background: Non-traditional risk factors including low levels of magnesium and high levels of uric acid have been associated with central obesity and cardiovascular disease.
Objective: To determine the association between waist circumference (WC) and non-traditional risk factors such as magnesium, phosphorus, and uric acid in indigenous children living at high altitudes. Methods: A total of 354 (166 M) indigenous school children, aged 9.6 + 2.3 years, were enrolled in a cross-sectional study in November 2011. Central obesity was defined as WC ≥ 90th percentile according to age and sex. Low magnesium and phosphorus levels were defined as serum magnesium <1.8 mg/dL and phosphorus <2.4 mg/dL. Hyperuricemia was defined as serum uric acid > 7 mg/dL. Results: The prevalence of central obesity was 6.8% (24/354). None of the children had hyperuricemia or low phosphorus levels. Hypoagnesemia was identified in 21.7% (57/263). There was a significant association between WC (z-score) and magnesium (r-015), uric acid (r0.28), phosphorus (r-0.30), HOMAIR (r0.49), triglycerides (r0.24), and HDL-C (r0.24). However, calcium, sodium, and potassium were not significantly associated with WC. As z-WC quartiles increased magnesium and phosphorus levels significantly decreased, whereas uric acid levels increased. Multiple linear regression analysis showed that z-WC was associated significantly and directly with uric acid (B0.31), triglycerides (B0.004), and HOMA-IR (B0.35); and inversely with magnesium (B-0.83) and phosphorus (B-0.25), adjusted for confounding variables (R2 0.34). Conclusion: Our results indicate that central obesity was associated significantly and inversely with magnesium and phosphorus and directly with uric acid in indigenous school children. Supplementation with magnesium and/or phosphorus could prevent future cardiovascular disease. Prospective and randomized studies should be performed to confirm these findings.Export Options
About this article
Cite this article as:
Hirschler Valeria, Esteban M., Gonzalez D. Claudio, Molinari Claudia and Castano Luis, Association Between Waist Circumference and Magnesium and Uric Acid in Indigenous Argentinean Children Living at High Altitude, Cardiovascular & Hematological Agents in Medicinal Chemistry 2016; 14 (2) . https://dx.doi.org/10.2174/1871529X16666161027165250
DOI https://dx.doi.org/10.2174/1871529X16666161027165250 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research Nanotubes at Neural and Immune Synapses
Current Medicinal Chemistry Editorial (Thematic Issue: Psychogeriatrics: An Interdisciplinary Approach)
Current Psychopharmacology Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer’s Disease
Current Alzheimer Research In vitro Bioaccessibility, Bioavailability, and Plasma Protein Interaction of New Oral Anticoagulants in the Presence of Macronutrients
Current Pharmaceutical Biotechnology Novel Vitreous Modulators for Pharmacologic Vitreolysis in the Treatment of Diabetic Retinopathy
Current Pharmaceutical Biotechnology Pulmonary Hypertension in the Perioperative Period-Focus on Current and Emerging Therapies
Recent Patents on Cardiovascular Drug Discovery Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
Current Drug Targets - Cardiovascular & Hematological Disorders Wounds Difficult to Heal: An Effective Treatment Strategy
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Vascular Pharmacology Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal
Current Drug Metabolism Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways
Current Diabetes Reviews The Effect of Serotonin 5-HT2 Receptor Inhibitor on Vasomotor Responses
Vascular Disease Prevention (Discontinued) PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation
Pharmaceutical Nanotechnology Structural Basis for Therapeutic Intervention of uPA/uPAR System
Current Drug Targets Critical Care for the Respiratory Specialist: Sepsis, Delirium and Long- Term Cognitive Dysfunction: Prevention with the Combination of Vitamin C, Hydrocortisone and Thiamine
Current Respiratory Medicine Reviews Editorial (Heart Failure: The Need for Global Health Perspective)
Current Cardiology Reviews Caspase-1-independent Maturation of IL-1β in Ischemic Brain Injury: is there a Role for Gelatinases?
Mini-Reviews in Medicinal Chemistry The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
Current Clinical Pharmacology